CorMedix (CRMD) EBT Margin Growth (1y) (2014 - 2025)

CorMedix (CRMD) EBT Margin Growth (1y) (2014 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (1y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1,526.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1,558.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -683.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 452.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 CorMedix 546.82 Mn 391.62 Mn 107.31 Mn 75.00

Historic Data

Download Data
DateValue
Dec 31, 2025 75.00
Sep 30, 2025 7,466.00
Jun 30, 2025 180,672.00
Dec 31, 2022 -1.38 Mn
Sep 30, 2022 -7.80 Mn
Jun 30, 2022 3.33 Mn
Mar 31, 2022 -8.73 Mn
Dec 31, 2021 -288,920.00
Sep 30, 2021 -1.54 Mn
Jun 30, 2021 -1.74 Mn
Mar 31, 2021 -1.18 Mn
Dec 31, 2020 -14.25 Mn
Sep 30, 2020 174,797.00
Jun 30, 2020 -3.81 Mn
Mar 31, 2020 -344,348.00
Dec 31, 2019 12.34 Mn
Sep 30, 2019 -609,618.00
Jun 30, 2019 9.70 Mn
Mar 31, 2019 3.95 Mn
Dec 31, 2018 1.92 Mn